BMR News Alert Biomed Realty Trust (BMR) 21.76 12/25/2014 19

New Post Public Reply Private Reply Replies (0) Message Board

Dec 25, 2014 at 8:37 PM

Biomed Realty Trust (BMR) 21.76 $BMR

REITs Equities Technical Coverage -- Brandywine Realty Trust, BioMed Realty Trust, Douglas Emmett, Retail Properties of America, and Macerich
PR Newswire - Fri Dec 19, 8:10AM CST
Investor-Edge has initiated coverage on the following equities: Brandywine Realty Trust (NYSE: BDN), BioMed Realty Trust Inc. (NYSE: BMR), Douglas Emmett Inc. (NYSE: DEI), Retail Properties of America Inc. (NYSE: RPAI), and The Macerich Company (NYSE: MAC). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Thursday, December 18, 2014, rallied as the Dow Jones Industrial Average finished at 17,778.15, up 2.43% and the NASDAQ Composite closed at 4,748.40, up 2.24%. The S&P 500 finished the session 2.40% higher at 2,061.23. During the trading session, all the ten sectors finished on a higher note. The S&P 500 Financials Sector Index ended the day at 333.23, up 2.43%, with the index advancing 4.12% in the previous three months. Register for your complimentary reports on these five stocks at:
BMR: 21.76 (-0.15), DEI: 28.75 (-0.13), BDN: 15.96 (-0.04), RPAI: 16.52 (+0.08), MAC: 83.33 (-0.21)

8 Stocks Taking Their Dividends Up A Notch
Dividends4Life - at Seeking Alpha - Fri Dec 12, 7:25PM CST

HASI: 14.11 (-0.15), AXS: 51.56 (-0.34), BMR: 21.76 (-0.15), GPT: 6.96 (+0.06), COR: 38.83 (+0.43), BMY: 59.15 (-0.01), VTR: 71.73 (-0.89), EIX: 66.75 (+1.41)

HFF closes sale of BioMed Realty Trust life sciences facility in Rockville, Maryland
Thomson Reuters ONE - Fri Dec 12, 3:02PM CST
WASHINGTON, D.C., December 12, 2014 - HFF announced today the sale of 9911 Belward Campus Drive, a 289,912-square-foot large scale biologics manufacturing facility in Rockville, Maryland, that is 100-percent leased through May 2026 to Human Genome Sciences, Inc., a wholly owned subsidiary of GlaxoSmithKline (NYSE: GSK).
HF: 36.08 (+0.46), BMR: 21.76 (-0.15), GSK: 42.85 (+0.11)

BioMed Realty sells Rockville, MD property; to book a $136M gain
Seeking Alpha - at Seeking Alpha - Thu Dec 11, 7:56AM CST

BMR: 21.76 (-0.15)

BioMed Realty declares $0.26 dividend
Seeking Alpha - at Seeking Alpha - Thu Dec 11, 7:37AM CST

BMR: 21.76 (-0.15)

BioMed Realty Trust Declares Fourth Quarter 2014 Common Stock Dividend
PR Newswire - Thu Dec 11, 7:35AM CST
BioMed Realty Trust, Inc. (NYSE: BMR) today announced that its board of directors has declared a fourth quarter 2014 dividend of $0.26 per share of common stock, representing a 4.0% increase over the company's third quarter 2014 dividend of $0.25 per share. The dividend is equivalent to an annualized dividend of $1.04 per common share.
BMR: 21.76 (-0.15)

BioMed Realty Sells Rockville, Maryland Asset For $322.5 Million, Resulting In $136.0 Million Net Gain On Sale
PR Newswire - Thu Dec 11, 7:30AM CST
BioMed Realty Trust, Inc. (NYSE: BMR) today announced that it has closed on the sale of its 9911 Belward Campus Drive property for approximately $322.5 million in gross proceeds, with a gain on sale of approximately $136.0 million, net of closing costs. The sale proceeds reflect a purchase price of $1,112 per square foot for the 289,900 square foot biological manufacturing facility located in Rockville, Maryland.
BMR: 21.76 (-0.15)

Wexford Science & Technology Announces 283,000 Square Foot Expansion of Wake Forest Innovation Quarter
PR Newswire - Tue Dec 09, 7:30AM CST
Wexford Science & Technology, a BioMed Realty Trust (NYSE: BMR) company, announced it will be developing an additional 283,000 square feet of laboratory and office space in Wake Forest Innovation Quarter in downtown Winston-Salem, North Carolina. Wake Forest Baptist Medical Center, an affiliate of Wake Forest University, has committed to a long-term lease for approximately 60% of the project for a new medical education building for Wake Forest School of Medicine.
BMR: 21.76 (-0.15)

BioMed Realty (BMR) Showing Signs Of Being Strong And Under The Radar
at The Street - Mon Dec 08, 8:48AM CST
Trade-Ideas LLC identified BioMed Realty (BMR) as a strong and under the radar candidate
BMR: 21.76 (-0.15)

Alexandria Real Estate REIT Inks Rx For Pharma Boom
at Investor's Business Daily - Tue Dec 02, 4:14PM CST
When it comes to developing cutting-edge real estate for Big Pharma and tech firms, Alexandria Real Estate Equities CEO Joel Marcus has refined a tried-and-true formula. Started by Marcus back in 1994, Alexandria (ARE) is a real estate investment...
BMR: 21.76 (-0.15), SPG: 185.12 (-1.22), ARE: 89.23 (-0.23), PFE: 31.42 (-0.03), ILMN: 186.22 (+2.72), LLY: 70.16 (+0.42), NVS: 93.91 (+0.66)

Biomed Realty Trust (BMR) Downgraded From Buy to Hold
at The Street - Fri Nov 28, 8:21AM CST
Biomed Realty Trust (BMR) has been downgraded by TheStreet Ratings from Buy to Hold with a ratings score of C+.
BMR: 21.76 (-0.15)

Citi Continues To Be A Deeply Discounted Stock
Abba's Aces - at Seeking Alpha - Wed Nov 26, 8:37AM CST

BMR: 21.76 (-0.15), SPY: 207.77 (+0.02), C: 54.54 (+0.12)

BioMed Realty Trust And Broad Institute Form Strategic Partnership To Promote Innovation And Collaboration Within The Life Science Industry
PR Newswire - Wed Nov 19, 8:00AM CST
BioMed Realty Trust, Inc. (NYSE: BMR) and the Broad Institute of MIT and Harvard today announced a strategic partnership to foster innovation and promote relationships between academia and the life science industry.
BMR: 21.76 (-0.15)

3 Buy-Rated Dividend Stocks: BMR, MIC, VTR
at The Street - Tue Nov 18, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
MIC: 69.24 (+1.45), BMR: 21.76 (-0.15), VTR: 71.73 (-0.89)

Dividend Challengers (And Near-Challengers): 44 Increase Expected By January 31
David Fish - at Seeking Alpha - Mon Nov 17, 3:57AM CST

WDFC: 84.59 (-0.01), EWBC: 38.89 (+0.09), TTC: 63.54 (+0.11), OCR: 73.20 (+0.33), GE: 25.83 (-0.05), MAIN: 30.13 (+0.19), HI: 34.20 (+0.19), DEI: 28.75 (-0.13), BLX: 31.27 (+0.12), THG: 71.98 (+0.36), RL: 184.35 (+0.70), BCPC: 66.80 (-1.55), AET: 89.59 (+0.14), VTR: 71.73 (-0.89), WDR: 49.37 (-0.17), TLLP: 56.04 (+0.46), PCBK: 14.28 (+0.04), EME: 44.55 (-0.10), EPR: 58.50 (unch), CHS: 16.12 (+0.07), LGCY: 11.86 (-0.49), BMR: 21.76 (-0.15), EMN: 76.80 (+0.04), INGR: 86.09 (-0.27), PRA: 47.52 (+0.05), CUBE: 22.59 (+0.08), DIS: 94.42 (-0.27), COR: 38.83 (+0.43), BMY: 59.15 (-0.01), MORN: 66.02 (+0.08), EXL: 13.37 (+0.03), RAS: 7.78 (-0.03), CLB: 122.57 (-1.35), RCII: 36.41 (+0.40), TESS: 28.99 (-0.10), BGS: 31.25 (-0.16), TOO: 26.47 (-0.62), FIBK: 27.46 (-0.17), MAA: 76.00 (-0.21), HEI: 61.21 (+0.56), JCI: 48.50 (-0.23)

What To Buy: Top 3 Buy-Rated Dividend Stocks: BMR, HCN, GEO
at The Street - Thu Nov 06, 9:31AM CST
These 3 dividend stocks are rated a Buy by TheStreet
BMR: 21.76 (-0.15), GEO: 40.40 (-0.20), HCN: 76.10 (-0.58)

Office REITs Stocks Under Review - Digital Realty Trust, BioMed Realty Trust, New York REIT, Boston Properties, and Mack-Cali Realty
PR Newswire - Fri Oct 31, 7:35AM CDT
Investor-Edge has initiated coverage on the following equities: Digital Realty Trust Inc. (NYSE: DLR), BioMed Realty Trust Inc. (NYSE: BMR), New York REIT Inc. (NYSE: NYRT), Boston Properties Inc. (NYSE: BXP), and Mack-Cali Realty Corporation (NYSE: CLI). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Thursday, October 30, 2014, the NASDAQ Composite ended at 4,566.14, up 0.37%, the Dow Jones Industrial Average advanced 1.30%, to finish the day at 17,195.42, and the S&P 500 closed at 1,994.65, up 0.62%. The gains were broad based as nine out of ten sectors ended the session in positive. The S&P 500 Financials Sector Index ended the day at 317.26, up 0.49%, with the index also advancing 2.96% in the previous three months. Register for your complimentary reports on these five stocks at:
BMR: 21.76 (-0.15), BXP: 135.18 (-1.10), DLR: 66.13 (-0.21), CLI: 19.06 (-0.03), NYRT: 10.82 (+0.02)

Biomed Realty Trust (BMR) CEO Alan Gold on Q3 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Oct 30, 6:35PM CDT

BMR: 21.76 (-0.15)

BioMed Realty beats by $0.04, beats on revenue
Seeking Alpha - at Seeking Alpha - Wed Oct 29, 10:49PM CDT

BMR: 21.76 (-0.15)

BioMed Realty Trust Reports Third Quarter 2014 Financial Results
PR Newswire - Wed Oct 29, 7:58PM CDT
BioMed Realty Trust, Inc. (NYSE: BMR), the leading real estate company focusing on life sciences, today announced financial results for the third quarter ended September 30, 2014.
BMR: 21.76 (-0.15)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Core Lab's Quarterly Grit: Navigating a Turbulent Market

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Wendy's Faces Takeover Bid Amid Strategic Focus Shift

Behind the Unsolicited Offer Folks, it looks like Wendy's (NASDAQ:WEN) got itself mixed up in some high-stakes shenanigans. An unsolicited, non-binding proposal slammed into them, courtesy of the Investor Group led by Trian Partners, Flynn Group LP, BlueFive Capital, and Sixth Street Partners, itching to scoop up every last piece of Wendy’s stock they ain't already...

Seasonal Hiring Booms as Firms Eye Long-Term Talent

A Strategic Shift in Seasonal Hiring It ain't just about the holiday rush anymore, folks. Companies are waking up to the idea that seasonal gigs are more than a temporary Band-Aid. This year, nearly 2 out of 5 companies are planning to bring more seasonal folks into the fold compared to last year. That means a good dose of them are looking for longer-term value—like...

BASIS Bellevue Expands with New K-4 Campus

A New Era for Young Learners in Bellevue When a community-driven school like BASIS Independent Bellevue makes a move to expand, it doesn't happen in a vacuum. They're not just building another campus—they're aiming to sculpt the future right here in Bellevue, and boy, do they have a plan. The new Lower School campus opening come Fall 2027 is dedicated to kiddos in...

Royce Global Trust: Insights on RGT's Performance

Analyzing Royce Global Trust's Approach When you dig into the Royce Global Trust portfolio, what emerges is a tapestry woven through decades of grit and determination in the investing world. This closed-end fund, trading under the symbol NYSE: RGT, is no stranger to the ebbs and flows of global markets. With every tick of the clock, speculation dances around this fund's...

Raleigh's Auction Direct Stresses Oil Changes

Keeping Engines Humming in Raleigh There's nothing quite like keeping an engine running like clockwork, especially in a place like Raleigh where folks rely on their rides day in and day out. That's where Auction Direct USA steps in, offering professional oil change services aimed at preserving the performance and reliability of used cars. A simple yet crucial service:...

Caylent's Strategic Moves Gain Eyeballs in ISG Report

Big Moves in the Contact Center Game There’s a buzz in the tech trenches, folks. Caylent just climbed onto the radar with its prominent mention in the 2026 ISG Provider Lens® Amazon Connect Ecosystem Report. Being dubbed a Product Challenger is no small feat when you’re pitted against some of the giants in tech. What’s their edge? An AI-first strategy, of course,...

Long March Reflections: Lesson of Adaptation Endures

Ever stood in a place where history feels so heavy you can almost touch it? That's Lazikou, a gorge in southern Gansu, where ninety years ago, young soldiers of China's Red Army faced a seemingly impassable barrier. Yet, they managed to climb, transform a military retreat into legend, and essentially shape the nation's path ahead. It's a feat that still sends ripples...

OLX Rolls Out New AI Tools Amid Trust Issues

A Grounded Approach to AI-Driven Market Evolution OLX Group's stepping into some turbulent waters, folks. They've dropped two new AI-assisted tools, Agentic Selling and DealFinder, while users are still trying to wrap their heads around trusting AI. Now, don't get me wrong, there's potential here—but the road ahead isn't paved with gold just yet. AI-Powered Tools Ready...

TransCode Pursues Strategic Moves for TTX-MC138 Value

A New Chapter for TransCode? Every once in a while, you find companies taking bold steps that make the market look twice. Today, that’s TransCode Therapeutics (NASDAQ: RNAZ) putting their chips on the table, determined to find the best route forward for their oncology efforts. Now, I’ve seen outfits talk plans without substance, but getting Tungsten Advisors on board...